Cargando…

Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C

BACKGROUND: Niemann-Pick disease type C (NP-C) is a rare neurovisceral lysosomal lipid storage disease characterized by progressive neurological deterioration. Published data on the use of miglustat in paediatric patients in clinical practice settings are limited. We report findings from a prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Héron, Bénédicte, Valayannopoulos, Vassili, Baruteau, Julien, Chabrol, Brigitte, Ogier, Hélène, Latour, Philippe, Dobbelaere, Dries, Eyer, Didier, Labarthe, François, Maurey, Hélène, Cuisset, Jean-Marie, de Villemeur, Thierry Billette, Sedel, Frédéric, Vanier, Marie T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465012/ https://www.ncbi.nlm.nih.gov/pubmed/22676771 http://dx.doi.org/10.1186/1750-1172-7-36

Ejemplares similares

Normalisation of brain spectroscopy findings in Niemann–Pick disease type C patients treated with miglustat
por: Sedel, Frédéric, et al.
Publicado: (2016)

Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study
por: Freihuber, Cécile, et al.
Publicado: (2023)

Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann–Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report
por: Cuisset, Jean-Marie, et al.
Publicado: (2016)

Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect
por: Nadjar, Yann, et al.
Publicado: (2018)

Miglustat in Niemann-Pick disease type C patients: a review
por: Pineda, Mercè, et al.
Publicado: (2018)

Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry
por: Patterson, Marc C., et al.
Publicado: (2020)

Long‐term survival outcomes of patients with Niemann‐Pick disease type C receiving miglustat treatment: A large retrospective observational study
por: Patterson, Marc C., et al.
Publicado: (2020)

Niemann-Pick disease type C
por: Vanier, Marie T
Publicado: (2010)

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
por: Wraith, James E, et al.
Publicado: (2009)

Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study
por: Patterson, Marc C, et al.
Publicado: (2015)

Longitudinal assessment of reflexive and volitional saccades in Niemann-Pick Type C disease during treatment with miglustat
por: Abel, Larry A., et al.
Publicado: (2015)

Favorable outcomes following early onset oral miglustat in early infantile Niemann Pick Type C
por: Curelaru, Shiri, et al.
Publicado: (2021)

Early detection of Niemann-pick disease type C with cataplexy and orexin levels: continuous observation with and without Miglustat
por: Imanishi, A., et al.
Publicado: (2020)

Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C
por: Fecarotta, Simona, et al.
Publicado: (2015)

Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat
por: Walterfang, Mark, et al.
Publicado: (2012)

Use of miglustat in a child with late-infantile-onset Niemann-Pick disease type C and frequent seizures: a case report
por: Skorpen, Johannes, et al.
Publicado: (2012)

A Suspicion Index to aid screening of early-onset Niemann-Pick disease Type C (NP-C)
por: Pineda, Mercedes, et al.
Publicado: (2016)

A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1
por: Neßlauer, Anna-Maria, et al.
Publicado: (2019)

Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability
por: Brogden, Graham, et al.
Publicado: (2020)

Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update
por: Patterson, Marc C., et al.
Publicado: (2017)

Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease
por: Seker Yilmaz, Berna, et al.
Publicado: (2020)

Efficacy and ototoxicity of different cyclodextrins in Niemann–Pick C disease
por: Davidson, Cristin D., et al.
Publicado: (2016)

Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR)
por: Bolton, Shaun C., et al.
Publicado: (2022)

Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review
por: Pineda, Mercedes, et al.
Publicado: (2019)

Consensus clinical management guidelines for Niemann-Pick disease type C
por: Geberhiwot, Tarekegn, et al.
Publicado: (2018)

Niemann-Pick disease type C symptomatology: an expert-based clinical description
por: Mengel, Eugen, et al.
Publicado: (2013)

Niemann-Pick C Disease Gene Mutations and Age-Related Neurodegenerative Disorders
por: Zech, Michael, et al.
Publicado: (2013)

Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment
por: Masingue, Marion, et al.
Publicado: (2017)

Niemann-Pick type C Suspicion Index tool: analyses by age and association of manifestations
por: Wraith, James E., et al.
Publicado: (2013)

Stem Cells and Niemann Pick Disease
por: Andolina, Marino
Publicado: (2014)

Stem Cells in Niemann-Pick Disease
por: Kim, Sun-Jung, et al.
Publicado: (2008)

Niemann-Pick disease and platelet dysfunction
Publicado: (2012)

Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
por: Davidson, Cristin D., et al.
Publicado: (2009)

LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease
por: Pettazzoni, Magali, et al.
Publicado: (2017)

The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients
por: Stirnemann, Jérôme, et al.
Publicado: (2012)

Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease
por: Torres, Sandra, et al.
Publicado: (2017)

Niemann-Pick Disease: An Approach for Diagnosis in Adulthood
por: Patiño-Escobar, Bonell, et al.
Publicado: (2019)

Diagnosis, quality of life, and treatment of patients with Hunter syndrome in the French healthcare system: a retrospective observational study
por: Guffon, Nathalie, et al.
Publicado: (2015)

Novel NPC1 mutations with different segregation in two related Greek patients with Niemann-Pick type C disease: molecular study in the extended pedigree and clinical correlations
por: Bountouvi, Evangelia, et al.
Publicado: (2017)

The prognostic value of Niemann-Pick C1-like protein 1 and Niemann-Pick disease type C2 in hepatocellular carcinoma
por: Chen, Ke-Ji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_atutp1ol5uoqn9q641fo25tndi